Decoded: Why Brazilian govt is under scrutiny over Bharat Biotech vaccine

The Brazilian media has reported that though Bharat Biotech initially quoted a price of $1.34 per dose, the Brazilian govt agreed to pay $15 per shot, having ignored Pfizer's offer at a lower price

Topics
Bharat Biotech | Coronavirus Vaccine | Jair Bolsonaro

Sohini Das  |  Mumbai 

A vaccine controversy is raging in Brazil and at the centre of it is Hyderabad-based Bharat Biotech. The Brazilian government is facing allegations of irregularities in the deal it signed with Bharat Biotech for procuring its Covid-19 vaccine, Covaxin, for its people.

Following these allegations, the Brazilian government has said that it will suspend the contract with Bharat Biotech on advice by its federal com­p­troller, the Compt­roller General of the Union (CG­U). What is at the root of the controversy and what do the two sides have to say about it? Let’s find ...

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Thu, July 01 2021. 06:10 IST
RECOMMENDED FOR YOU